Thursday, September 30, 2021
Preschool Funding in $3.5 Trillion Spending Bill Is Modeled After Failed Head Start Program
Fraud, abuse, poor outcomes, and high costs. Those aren’t exactly hallmarks of successful programs, and yet, those pushing for universal preschool and child care in the $3.5 trillion spending bill currently making its way through Congress have landed on the ineffective federal Head Start program as their model.
“It is very much built around the Head Start model. We need to make sure that the Head Start model is sewn into the fabric of this new system,” Tommy Sheridan, deputy director of the National Head Start Association, told Politico.
How well has this model served families?
The Head Start program, a relic of President Lyndon Johnson’s “War on Poverty,” was launched in 1965, enrolling 560,000 children in the new, federally funded eight-week summer program. At the time, proponents were clear that Head Start’s “sole purpose” was to “prepare [children] for elementary school.”
As the Chicago Tribune put it at the time, “the program is designed to make the pupils’ first taste of school also a taste of success.”
Unfortunately, more than half a century later, participating students have not had that taste of success.
The Department of Health and Human Services, which administers Head Start, revealed in December 2012 that the nearly $8 billion Head Start program has little to no impact on the cognitive, social-emotional, or health outcomes of participants, or the parenting skills of their parents.
Alarmingly, participation in Head Start actually had some negative effects on enrolled children. Federal researchers reported worse peer relations and lower teacher-assessed math ability for Head Start children.
It’s no wonder then that the results of the HHS evaluation were released on a quiet Friday before Christmas in 2012, when most of the federal government and its employees had left Washington.
As Heritage Foundation senior research fellow Jay Greene commented at the time, HHS “might as well put the results on display in a locked filing cabinet in a disused lavatory behind the sign that says ‘Beware of the leopard.’” (The Daily Signal is the news outlet of The Heritage Foundation.)
The bad outcomes don’t end there.
In 2010, the Government Accountability Office found several Head Start centers around the country actively counseling families to underreport their incomes in order to appear eligible for services. Head Start employees even assured the undercover families that no one would check to see if their information was correct, doctored forms to hide income, and told applicants to misrepresent their eligibility.
And as Heritage Foundation research fellow Jonathan Butcher has reported, the Office of Inspector General in the Department of Health and Human Services found “significant lapses in safety practices” in numerous states.
Among the 175 Head Start centers the inspector general investigated:
[N]one complied fully with federal Head Start or state requirements to protect children from unsafe materials and equipment, and 21 of 24 grantees did not comply fully with federal Head Start or state requirements to conduct criminal records checks, conduct recurring background checks, document criminal records checks, conduct checks of child care exclusion lists, or conduct checks of child abuse and neglect registries.
The program is also increasingly expensive.
The rate of spending on Head Start has exceeded enrollment growth over the decades, and—as David Armor, professor emeritus, and Sonia Sousa, affiliate assistant professor of public policy, at George Mason University explain—had tripled to nearly $7 billion annually by 2000, with per capita spending exceeding $8,000 per child (up from $5,000 per child in real terms throughout the 1970s and 1980s).
Head Start spending crossed the $9 billion mark in 2014 (exceeding $9,000 per child per year). Today, annual Head Start appropriations total $10.7 billion annually, or more than $10,200 per participant.
Much of that spending supports Head Start staff salaries, as the program now acts as a federal jobs program for a quarter of a million adults. More than 265,000 adults were on staff with Head Start in 2018, 22% of whom were parents of children currently or formerly enrolled in the program.
Since 1965, Head Start has been a sinkhole for taxpayer dollars and an ineffective education program for children. And yet, proponents—hand in glove with Congress—want to model hundreds of billions of dollars in the $3.5 trillion tax-and-spending package on it.
It’s yet one more indication that President Joe Biden’s plan doesn’t “Build Back Better.” It’s building back bureaucracy.
*********************************************
Parents, Lawmakers Sue Over New York’s School Mask Mandate
A group of New York parents and two local legislators are suing to overturn the state’s requirement for school children to wear masks.
They allege the mandate was issued illegally and wouldn’t stand up to scrutiny if the state tried to pass it through the correct procedures.
They’re asking the court to toss the mandate as “arbitrary and capricious.”
State Sen. George Borrello (R-Sunset Bay), one of the plaintiffs, said he’s hearing the majority of his constituents in the Niagara Falls area are against masking children. His gripe, however, is mainly with what he sees as the usurpation of power by the governor.
“My focus is on what I believe is the unconstitutional overreach of the executive,” he told The Epoch Times.
Since the onset of the pandemic, he said he’s seen the legislature be all too willing to abdicate its responsibilities and hand over near-absolute mandate to the administration.
“I’m not against children wearing masks in school. I’m not even necessarily against mandates in certain circumstances,” he said. “But to circumvent the laws and just absolutely shred the separation of powers in your state is a scary situation.”
The office of Gov. Kathy Hochul didn’t respond to a request for comment. A spokeswoman for the state’s Department of Health (DOH) told The Epoch Times via email that the agency doesn’t comment on pending litigation.
The mandate was announced by Hochul on Aug. 24, the day she assumed office after the resignation of Gov. Andrew Cuomo. The DOH promulgated it three days later, saying school children and staff, from prekindergarten to 12th grade, have to wear masks at all times regardless of vaccination to prevent the spread of the COVID-19 disease. The rule is based on recommendations by the Centers for Disease Control and Prevention.
The rule was issued under emergency powers, skipping the usual public comment period.
In such cases, the state law requires the administration to explain why the rule is “necessary for the preservation of the public health, safety or general welfare” and why the regular process would go against “public interest.” The explanation should also include the expected duration of the emergency.
The suit lists several precedents that indicate the state needs to be specific in its justification. It argues the administration was not.
“Department of Health’s Notice of Emergency Adoption is a boilerplate statement composed of a myriad of inaccuracies regarding the present situation in New York as it relates to COVID-19,” it states.
The suit goes on to allege the state didn’t go into details because it would have revealed the lack of a proper justification.
The rule notice says that since the emergence of the CCP (Chinese Communist Party) virus, which causes COVID-19, New York has “become the national epicenter of the outbreak.” But the state hasn’t been the epicenter for over a year now, the lawsuit says.
The notice mentions the disaster emergency declared by the previous governor, Andrew Cuomo. But that one expired in June and the new governor, Kathy Hochul, hasn’t declared a new one.
The notice does mention that the current dominant variant of the virus is “twice as transmissible” and that detected infections had increased tenfold in the state. But two “conclusory sentences regarding the Delta variant are not specific reasons that would satisfy the issuance of an emergency regulation impacting millions of children in the State of New York,” the suit argues.
The suit goes further by claiming the DOH doesn’t have the authority to issue the rule to begin with.
“DOH has, as an administrative agency, the authority to fill in the gaps of broad legislation describing the overall policies to be implemented. It does not, however, have the authority to write legislation on a clean slate, creating its own comprehensive set of rules without the benefit of legislative guidance,” it says.
The suit also cites articles by several experts, including the opinions of two doctors and a neuropsychologist all opposing mask mandates for children. They said children do not face a significant risk from the virus and rarely spread it to others, based on their reading of the scientific literature on the subject. Masking, on the other hand, has a significant negative impact on children, they say, preventing children from reading lip movement and facial expressions, a crucial aspect of child’s development, and may have some negative health effects too.
*****************************************
Virginia Congressman Introduces Legislation to Prohibit Critical Race Theory at Federally-Funded Schools
Virginia Congressman Rep. Bob Good (R) is introducing legislation Wednesday that would make teaching Critical Race Theory (CRT) at federally-funded schools a civil rights violation.
Good’s bill, the Protecting Students Civil Rights Act, would bar CRT and any other form of curriculum resembling it from permeating schools. He noted that his constituents have voiced concerns to him over what their children are being taught in schools, including that their children are being “divided by race.”
"We are introducing a bill that will make it a civil rights violation to teach critical race theory or anything resembling it by any other name in our schools," Good told Fox News on Tuesday.
“We have constituents reaching out to us from all across our district very concerned about what’s being taught in their schools,” Good added. “Their children are being divided by race. They are being taught, again, that they are responsible for the sins of their past. If they’re a white kid, they are undeniably an oppressor because of their race. If they’re a black kid, they’re undeniably a victim because of their race. We don’t believe that kids look at each other that way.”
CRT in public schools has been a hot-button issue across the country, especially in Virginia. Loudoun County, as we’ve covered, has made national headlines for pushing its agenda of CRT curriculum, transgender pronouns, and explosive school board meetings as a result.
Good, who assumed office in January, has been a vocal opponent of CRT, and specifically, the “1619 Project,” the New York Times’ journalism ongoing “project” on the history of racism in America. The “1619 Project” is reportedly being taught in some schools across the country, as well as other forms of “anti-racism” curriculum.
"What we hope to accomplish is to advance Martin Luther King's principles, which were to judge people by the content of their character and not by the color of their skin," Bob said of the legislation to Fox News. “Our race doesn’t determine our future. Our actions, our values, and the things that we achieve as individuals determine our future.”
***********************************
My other blogs: Main ones below
http://dissectleft.blogspot.com (DISSECTING LEFTISM)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)
http://snorphty.blogspot.com/ (TONGUE-TIED)
*******************************
Wednesday, September 29, 2021
The CDC’s COVID Failures Mount
What grade does America’s premier public health agency deserve vis-à-vis the biggest public healthcare threat the country has faced in generations? The short answer would be “a failing grade.”
Throughout the course of the COVID pandemic, the Centers for Disease Control and Prevention (CDC) has repeatedly misinterpreted data, misinformed the public, and allowed political considerations to direct its guidelines rather than holding strictly to the known science.
The result has been widespread confusion and deep distrust in an institution that should seek to avoid any whiff of political considerations in its decision-making. Fewer Americans trust the CDC today than did before the pandemic, and the lion’s share of the blame rests almost entirely on those leading the CDC.
Although he doesn’t hold a position at the CDC, Dr. Anthony Fauci, whom Donald Trump tagged as the lead medical professional to communicate with the American people regarding the novel virus, has seemingly served as role model to the CDC’s operation. Fauci was perhaps Trump’s biggest blunder, because the Beltway’s highest-paid bureaucrat arguably cost Trump a second term through his own continual display of a total lack of humility and honesty. The CDC seemed to mimic his approach.
“The CDC is supposed to be America’s frontline institution in the fight against infectious disease,” Peter Suderman pointedly observes. “Its job is to analyze viral threats, track their spread and development, and provide the public with relevant information about how to respond to outbreaks. Not only did the agency do this job poorly in the early stages of the pandemic, but it actively hindered efforts that would have greatly improved America’s response, and it made planning errors that were both predictable and avoidable. At nearly every stage of the pandemic, the CDC got things wrong and got in the way. Its failures almost certainly made America’s pandemic worse.”
From foulups of COVID testing kits to promulgating misleading information, from allowing a partisan teachers union to dictate guidance to outrageously overstepping its boundaries with things like the eviction moratorium, the CDC failed the country. Making matters worse has been the CDC’s elitist and condescending attitude toward the American public. Rather than seeing itself as primarily a public health advisory agency, those leading the CDC seemed to see the agency as primarily a means to wield governing authority over the American people.
“The root of the problem is the agency’s self-conception: It sees itself as the ultimate arbiter of what is true and what to do on all matters of infectious disease,” Suderman further notes. “In essence, the CDC believes there is no other authority besides the CDC, so it shuts out private labs from the testing process, insists that its faulty tests actually work pretty well long after problems arise, sticks with overly complicated plans that bog down processes, and resists calls to update its guidance, even when that guidance makes living ordinary life difficult or impossible.”
The CDC’s guiding concern seems to have been politics, not science, which has created greater distrust within the minds of many Americans. Of course, the CDC’s “my way or the highway” approach will not lend itself to much introspection, something that is desperately needed if those who run the agency hope to regain any trust from the public. If this is the best Americans can expect from the CDC, then who needs it?
https://patriotpost.us/articles/83019-the-cdcs-covid-failures-mount-2021-09-28
*********************************************US expert says virus strain is mutating 'so much faster than we expected'
A new highly contagious variant of Covid-19 is the fastest mutating strain yet and three doses of vaccine will be required to protect against it, a U.S. epidemiologist has warned.
Scientists say the C.1.2 strain in South Africa has a mutation rate of 41.8 mutations per year, almost double the current global mutation rate seen in any other variant of concern so far.
The strain was first identified by scientists in South Africa in May and has since been found in England, China, the Democratic Republic of the Congo, Mauritius, Portugal Switzerland and even New Zealand.
Not a lot is yet known about C.1.2, which is yet to make its way to Australia, where there have been outbreaks of the Delta strain, chiefly in Sydney and Melbourne.
But this new strain has experts on edge, including Dr Eric Feigl-Ding, an epidemiologist and Senior Fellow at the Federation of American Scientists in Washington DC.
'It's got lots of troubling mutations and it's the most mutative of all variants,' he told the Today show on Wednesday.
'It's the most genetically distanced from the Wuhan 1.0 virus. Whether or not it's the next big thing, it's not necessarily that, it's the fact that the virus is mutating so much faster than we expected.'
Dr Feigl-Ding, who is a member of the World Economic Forum's Global Shapers program, a Soros Fellowship recipient and a former Democratic Party candidate, advocated a Covid elimination strategy.
'We can't just keeping boosting the vaccines,' Dr Feigl-Ding said.
'We have to basically stop the transmission worldwide because the more bodies we give the virus, the more practice chances the virus will eventually adapt and become even more evasive or contagious.'
He also warned two doses of the vaccine may not be enough with Israel already introducing third booster shots.'
'Unless you're triple vaxxed, you're not considered fully vaxxed. And that approach as much as it sucks, it is the reality that with the face of these new variants,' Dr Feigl-Ding said.
'Right now vaccines do work, but obviously the work against hospitalisations and deaths really well.
'But for just casual breakthrough mild infections, with Delta it's taught us that there's a lot more breakthroughs than we know and after six months it does tend to wane a little bit.
'This is why the sooner we end it, the sooner we can stop dealing with these upgrade software upgrade patches that we have do with the vaccine.
**********************************************
Here's what we know about Delta now, after months spent fighting it
Delta was recognised as a SARS-CoV-2 variant of concern in May 2021 and has proved extremely difficult to control in unvaccinated populations.
Delta has managed to out-compete other variants, including Alpha. Variants are classified as "of concern" because they're either more contagious than the original, cause more hospitalisations and deaths, or are better at evading vaccines and therapies. Or all of the above.
So how does Delta fare on these measures? And what have we learnt since Delta was first listed as a variant of concern?
How contagious is Delta?
The R0 tells us how many other people, on average, one infected person will pass the virus on to.
Delta has an R0 of 5-8, meaning one infected person passes it onto five to eight others, on average. This compares with an R0 of 1.5-3 for the original strain. So Delta is twice to five times as contagious as the virus that circulated in 2020.
What happens when you're exposed to Delta?
SARS-CoV-2 is the virus that causes COVID-19. SARS-CoV-2 is transmitted through droplets an infected person releases when they breathe, cough or sneeze.
In some circumstances, transmission also occurs when a person touches a contaminated object, then touches their face.
Once SARS-CoV-2 enters your body — usually through your nose or mouth — it starts to replicate.
The period from exposure to the virus being detectable by a PCR test is called the period. For Delta, one study suggests this is an average of four days (with a range of three to five days). That's two days faster than the original strain, which took roughly six days (with a range of five to eight days).
The virus then continues to replicate. Although often there are no symptoms yet, the person has become infectious.
People with COVID-19 appear to be most infectious two days before to three days after symptoms start, though it's unclear whether this differs with Delta.
As the virus replicates, the viral load increases. For Delta, the viral load is up to roughly 1,200 times higher than the original strain.
With faster replication and higher viral loads it is easy to see why Delta is challenging contact tracers and spreading so rapidly.
What are the possible complications?
Like the original strain, the Delta variant can affect many of the body's organs including the lungs, heart and kidneys.
Complications include blood clots, which at their most severe can result in strokes or heart attacks.
Around 10-30 per cent of people with COVID-19 will experience prolonged symptoms, known as long COVID, which can last for months and cause significant impairment, including in people who were previously well.
Longer-lasting symptoms can include fatigue, shortness of breath, chest pain, heart palpitations, headaches, brain fog, muscle aches, sleep disturbance, depression and the loss of smell and taste.
Is it more deadly?
Evidence the Delta variant makes people sicker than the original virus is growing.
Preliminary studies from Canada and Singapore found people infected with Delta were more likely to require hospitalisation and were at greater risk of dying than those with the original virus.
In the Canadian study, Delta resulted in a 6.1 per cent chance of hospitalisation and a 1.6 per cent chance of ICU admission. This compared with other variants of concern which landed 5.4 per cent of people in hospital and 1.2 per cent in intensive care.
In the Singapore study, patients with Delta had a 49 per cent chance of developing pneumonia and a 28 per cent chance of needing extra oxygen. This compared with a 38 per cent per cent chance of developing pneumonia and 11 per cent needing oxygen with the original strain.
Similarly, a published study from Scotland found Delta doubled the risk of hospitalisation compared to the Alpha variant.
How do the vaccines stack up against Delta?
So far, the data show a complete course of the Pfizer, AstraZeneca or Moderna vaccine reduces your chance of severe disease (requiring hospitalisation) by more than 85 per cent.
While protection is lower for Delta than the original strain, studies show good coverage for all vaccines after two doses.
Can you still get COVID after being vaccinated?
Yes. Breakthrough infection occurs when a vaccinated person tests positive for SARS-Cov-2, regardless of whether they have symptoms. Breakthrough infection appears more common with Delta than the original strains.
Most symptoms of breakthrough infection are mild and don't last as long.
It's also possible to get COVID twice, though this isn't common.
How likely are you to die from COVID-19?
In Australia, over the life of the pandemic, 1.4 per cent of people with COVID-19 have died from it, compared with 1.6 per cent in the United States and 1.8 per cent in the United Kingdom.
Data from the United States shows people who were vaccinated were ten times less likely than those who weren't to die from the virus.
The Delta variant is currently proving to be a challenge to control on a global scale, but with full vaccination and maintaining our social distancing practices, we reduce the spread.
https://www.abc.net.au/news/2021-09-29/covid-delta-variant-what-the-science-says/100497804
******************************************Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Tuesday, September 28, 2021
Pfizer begins late-stage clinical trial of oral drug to prevent COVID-19 in people who have been exposed to symptomatic patients
Pfizer Inc has begun late-stage clinical trials of an oral drug that could prevent COVID-19 among those who have been exposed.
The drugmaker, which developed the first authorized COVID-19 vaccine in the U.S. with Germany's BioNTech SE, has previously said the antiviral candidate showed 'potent' activity against the virus in lab studies.
Pfizer's candidate, which is called PF-07321332, belongs to a class of drugs known as protease inhibitors. The pill would work by inhibiting an enzyme that the coronavirus uses to make copies of itself inside human cells.
The New York-based company and its rivals, including Merck & Co Inc in the U.S. and Swiss pharmaceutical Roche Holding AG, have been racing to develop an easy-to-administer antiviral pill for COVID-19.
Protease inhibitors have been effective at treating other viral pathogens such as HIV and hepatitis C virus, both on their own and in combination with other antivirals, the company said.
Pfizer believes this class of molecules may provide well-tolerated treatments against COVID-19, as currently marketed therapeutics that work on the same lines have not reported safety concerns.
'With the continued impact of COVID-19 around the world, we believe that tackling the virus will require effective treatments for people who contract, or have been exposed to, the virus, complementing the impact that vaccines have had in helping quell infections,' said Dr Mikael Dolsten, chief scientific officer at Pfizer, in a statement.
'If successful, we believe this therapy could help stop the virus early - before it has had a chance to replicate extensively - potentially preventing symptomatic disease in those who have been exposed and inhibiting the onset of infection in others.
The Phase II/III trial is a randomized, double-blind trial in which some participants will be given the drug and others the placebo, but even researchers won't know what pill the volunteers.
The study will test Pfizer's drug in up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic Covid infection.
In the trial, half of the participants will be given the pill plus a low dose of ritonavir, an older medication widely used in combination treatments for HIV infection, and the other half will be given a placebo.
Volunteers will be required to take the pills they are given twice daily for either five days or 10 days.
Scientists will assess whether the pill is effective at preventing infection and its symptoms up to 14 days after being exposed.
Pfizer has also started another study of PF-07321332 in non-hospitalized, symptomatic adult patients.
To date, Gilead Sciences' remdesivir is currently the drug fully approved by the U.S. Food and Drug Administration (FDA) for the treatment of COVID-19.
However, the agency has granted emergency use authorization to two combination therapies, one from Eli Lilly and the other by Regeneron.
Pfizer's announcement comes as Merck and partner Ridgeback Biotherapeutics also recently launched a late-stage trial of their experimental drug molnupiravir for prevention of the COVID-19 infection.
Molnupiravir is also being studied in a late-stage trial in non-hospitalized patients to see if it reduces the risk of hospitalization or death.
*********************************************
Alberta, Canada is counting ANY student who calls out sick as being a COVID case: Those who refuse testing will be added to the list
Students in Alberta who call out sick will be counted as COVID-19 cases as infections in the Canadian province surge - causing furious parents to accuse government officials of fear-mongering to maintain their grip on power after the new ruling by the Chief Medical Officer of Health.
'If individuals choose not to get tested for COVID-19 but are home with an illness they are now counted in the list as being part of that outbreak, and so it's less dependent on needing a test to be part of identifying where there is an issue,' said Deena Hinshaw, the province's top doctor, on Thursday.
In August, Hinshaw apologized for treating the pandemic as an 'endemic' in the early stages of COVID and for the fear and uncertainty that followed in the months after.
In Alberta schools, students who come in contact with others infected with COVID-19 are not required to quarantine and a contract tracing measure is not in place.
The government has also announced that data on how many schools have COVID-19 outbreaks will not be released, prompting outrage from parents who feel they have the right to know.
Hinshaw said the current framework had been implemented based on previous evidence from other jurisdictions.
She has said it is necessary for schools to assume anyone at home is a positive case of COVID-19 because obtaining data on COVID-19 transmissions from pubic health agencies would violate the privacy of students and staff.
Hinshaw insisted that the method was in place so schools could promptly alarm public health officials of a possible outbreak, in order to add an extra layer of protection and mitigate the spread.
'In schools, we are taking the approach that an illness that fits that definition - respiratory illness- is treated the same way whether it is COVID or not, so additional measures can be put into place,' Hinshaw said.
Social media users on Twitter disapproved of the measure they deemed alarmist and panic-driven.
Ezra Levant, a reporter for Rebel News, shared a clip of Hinshaw and tweeted: 'To maintain a mass psychology of panic and fear, Alberta's corrupt public health bureaucrat now automatically counts anyone staying home from any illness as a Covid case.'
Others complained about the continued restrictions. 'These 'So Called Experts' are power hungry and will never give us back our freedoms,' said Dougle Affan.
Another user wrote: 'Broken leg, refuse covid test, counted as a Covid case. FFS, the world is careering down a very dark path. How are they getting away with this, why are journalists not taking them to task?'
Alberta, a province that aggressively advertised its 'best summer ever,' is now struggling with a surge in COVID-19 cases.
With its healthcare system strained, and anti-vaccine and anti-mask sentiments growing among residents, public health officials are urging politicians to improve the loose restrictions that are in place.
There were 1,061 people hospitalized with COVID-19 in Alberta on Thursday. Of the 818 non-ICU, 75.5% were unvaccinated or partially vaccinated. Of the 243 in ICU, 91.7% were unvaccinated or partially vaccinated.
More than 60 doctors penned a letter to premier Jason Kenney, who has fervently opposed a lockdown, warning him about the dire conditions and low-room capacity at hospitals.
'Our healthcare system is truly on the precipice of collapse. Hospitals and ICUs across the province are under enormous strain and have reached a point where it is unclear if, or for how much longer, we can provide safe care for Albertans.' The Guardian reported.
A public health emergency has now been declared and military help has been requested to transport patients to others provinces as hospitals are working on full capacity.
Kenney has retracted his triumphant approach during the summer but still refused to order a lockdown because it made 'no sense for the 80 percent of the population that is vaccinated.'
'I know that we had all hoped this summer that we could put Covid behind us once and for all, that was certainly my hope,' he said. 'It is now clear that we were wrong, and for that I apologize.'
Kenney introduced some restrictions and promised to give more resources to hospitals when cases rose exponentially, but it was too little too late, medical officials have said.
In Alberta, there are currently 22,320 COVID-19 cases and 2,622 people have died of of the illness since the pandemic started. In May, the province had the worst rate of COVID-19 in North America
https://www.dailymail.co.uk/news/article-10034075/Alberta-schools-count-sick-home-COVID-case.html
**************************************IN BRIEF
Joe Biden slams horse-mounted agents who are overwhelmed because of his own policies (CNS News)
Border agents “dumbfounded” by Biden’s promise to “fry our agents”: “He just started a war with Border Patrol” (Not the Bee)
Jen Psaki: It’s not “constructive” for the president to visit the southern border (Daily Wire)
DHS secretary: We probably released around 12,000 Haitians (Hot Air)
Biden defends his social agenda bill, wrongly claiming the cost will be zero (Washington Post)
Nancy Pelosi sets Thursday vote on “infrastructure,” eyes smaller social spending bill (Reuters)
House Democrats pass bill to end nearly all restrictions on abortion (CNS News) | Abortion bill protects “transgender men” (Free Beacon)
AOC apologizes for “present” vote on Israel’s Iron Dome, explains her crocodile tears (Fox News)
Runs in the family: Chris Cuomo accused of sexually harassing former boss at 2005 party (New York Post)
Under U.S. sanctions, Iran and Venezuela strike oil export deal (Reuters)
The United States and Pakistan face each other again on Afghanistan threats (AP)
Turkey’s president defiant about acquiring Russian missile defense system despite potential risk for U.S. (CBS News)
Chairman disbands panel investigating COVID-19’s origins, saying its links to a nonprofit that worked with a Chinese lab raises bias concerns (Business Insider)
WHO relaunching probe into pandemic origins (Daily Wire)
Social Democrats narrowly beat Angela Merkel’s bloc in German vote (Fox News)
New video of January 6 depicts disorder and disrespect, not violent insurrection (Just the News)
Police academies face recruiting drought after year of relentless cop demonization (National Review)
Delta wants airlines to share no-fly lists to keep crap passengers out of the skies (Gizmodo)
Policy: Pelosi’s “abortion for all” bill is more radical than Roe (Heritage Foundation)
******************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Monday, September 27, 2021
Is there likely to be a religious exemption for the COVID-19 vaccine?
Comments from Australia. Compelled medical treatment was first introduced into Australia in order to give blood transfusions to the children of Jehovah's witnesses
Since the recent round of stay-at-home orders were introduced in Sydney and Melbourne, religious messages and motifs have been popping up at loosely defined "anti lockdown" protests across Australia.
As one widely photographed sign at a Sydney demonstration in July declared: "The blood of Christ is my vaccine."
No major religion in Australia has expressly told its followers to forgo vaccination against COVID-19. In fact, many faith leaders have played a key role in combating vaccine misinformation in their communities.
But as the above sign — and others like it — indicate, that doesn't mean people aren't being guided by their beliefs when deciding to refuse the jab.
It's this grey area that Dr Renae Barker, an expert in law and religion at the University of Western Australia, said will make it difficult for the legal system to rule on whether policies that bar unvaccinated people from participating in certain activities — as already in place in Victoria, NSW and some industries — warrant a religious exemption provision.
And the question is already playing out internationally, particularly in the United States, where thousands of people have already sought exemptions from vaccine mandates on religious grounds.
"Do I think we need to have a conversation about [religious] exemptions? Possibly," Dr Barker said, "I don't think that conversation will go very far. I think politicians will very quickly say health, in this case, trumps freedom of religion."
Australia's history of religious exemptions
Looking back through Australia's recent history, there's only been one religion that has successfully lobbied for a vaccine exemption. That is the Christian Scientists, a small sect of Christianity who believes in prayerful healing to manage their health.
According to the 2016 Census, just 974 Australians reported they were Christian Scientist, out of 12 million people identifying as Christian more broadly.
In 1998, the church was granted an exemption to the Federal Government's new "no jab, no pay" laws that meant children had to be vaccinated to receive childcare and family benefits. They were the only religion to receive such an exemption — which required parents and carers to provide a letter from a church leader — sparking unfounded fears the decision would cause a flood of new converts eager to bypass the laws.
But when it comes to COVID-19, the Christian Scientists are taking a different approach.
"As far as our practice of trusting our problems to God prayerfully, that hasn't really altered," said Edwina Aubin, a Christian Scientist practitioner from Brisbane. "We're not 'anti-vax' as such, and neither are we 'pro-vax' … if it's what's required, then that's what we'll do."
Ms Aubin explains that while the majority of the church's members feel they don't require traditional medicine, instead relying on prayer and the support of practitioners in the church, there's nothing stopping them from seeking it out — whether it's a legal requirement or not.
But even so, she said the question of whether to get the COVID-19 jab "probably has challenged many Christian Scientists". In making the decision, she pointed to another core tenet of their beliefs: "Do to another what you want done to yourself."
"I certainly know those who have chosen to be vaccinated have done so because they feel it's the more loving thing to do to allay the fears of those around them," she said.
"We're conscious that we don't want to make another fearful because of our stance, and if there's no fear in our thought to go ahead and be vaccinated then that's a more loving step to take."
It's this approach that led the government to scrap religious exemptions to immunisation completely in 2015, declaring the policy no longer necessary.
But COVID-19 has brought with it fresh debate around religious and conscientious objection to vaccination, particularly as states move towards a system of different rules for the unvaccinated.
Dr Barker said just because a religion doesn't formally ban or mandate something doesn't mean all adherents will comply: "Each individual does often have an individual interpretation of their requirements."
But this is an area where Australian courts have "really struggled" to make a legal distinction, she said. "And it's a very important distinction".
The challenge for the courts
Dr Barker said there's been a handful of cases where Australian courts have been asked to determine whether a person really did something on the basis of their religion, which is protected under anti-discrimination legislation.
To highlight the distinction she provides this example: If someone chooses to be vegan because they believe it is good for their health and their workplace refuses to provide vegan options at a lunch event, it is not discrimination. But, if someone abstains from eating animal products because it is part of their religion and the workplace fails to accommodate this, it is.
This becomes more complicated when someone's religious belief does not align with the commonly held practices of their organisation.
"The courts struggled with this idea that even different groups within the one larger religion might have different views and I suspect the courts will struggle even more with the idea that individuals within a religion will have a different view," Dr Barker said.
"Religious practice and religious belief are very nuanced, and it's very diverse, and even if we don't think people are getting their religion 'right' they sincerely believe they are.
"And it's a very challenging thing to do for a secular lawmaker, be that a legislature or a court, to say to that person 'we think you've interpreted your religion wrong'."
This means that, in the absence of religious leaders telling their followers they shouldn't be vaccinated, any push for religious exemptions would depend on the individual being able to demonstrate why they believe their decision is tied to their religious beliefs.
How it's being handled elsewhere
International law enshrines the right of all citizens to freely practise their religion, but that doesn't mean it's without limits.
Article 18 of the International Covenant of Civil and Political Rights (ICCPR) sets out that these limits include what is necessary to protect "public safety, order, health or morals".
In the United States, where COVID-19 vaccination requirements vary by state, the debate over how far religious freedom can stretch in the face of a pandemic is in full swing.
Just last week, the Associated Press reported that there had been a flood of workers in industries where the jab has been made mandatory submitting letters from faith leaders despite no major religion expressly discouraging people from the vaccine.
This includes about 2,600 Los Angeles Police Department employees and thousands of government workers in Washington.
Workers looking for a way out have also been sharing tips online about how to request a religious exemption, the New York Times reported this month, and seeking out obscure religious organisations sympathetic to their plight.
But according to Douglas Laycock, a professor of law at the University of Virginia who specialises in religious liberties, it's unclear whether there's even a legal basis for such exemptions.
Unlike Australia, most US states allow for some form of vaccination exemption for religious reasons, although often this is only for specific groups such as school children. In some instances, these exemptions could be used in a state government context, but they would not cover national rules, such as President Joe Biden's sweeping vaccine mandate that covers about 100 million people.
Then there's the issue of private employers who may establish their own exemption system, but, as Professor Laycock wrote in The Conversation, this is not required by federal law.
Given the sudden influx of people seeking religious exemptions, and the growing anti-vaccination movement, the question then becomes how to determine whether someone's objection to the vaccine is a legitimately religious one.
A different vaccine problem
Another pressing question for religious institutions is how they will manage in-person services if rules are put in place barring unvaccinated people from gathering.
Under NSW's plan to reopen, only fully vaccinated people will be able to attend places of worship once the state's vaccination rate hits 70 per cent. In Victoria, religious services were notably absent from Premier Daniel Andrews's announcement last week.
If widespread and long-term rules are put in place limiting who can attend religious services, it will put faith leaders in the difficult position of having to turn people away.
"A number of churches are expressing concern that this is theologically a problem for them," Dr Barker said. "As long as religious organisations are treated the same as other equivalent secular organisations, and the usual example given is going to the cinema or theatre, it will be very hard for them to challenge."
Just last week, Bishop Paul Barker from the Anglican Diocese of Melbourne said he feared those who were not vaccinated would be turned into "the lepers of Jesus' day".
"We're anxious about where society might end up with division lines. If it's long term, that's one of our concerns," he said.
Ms Aubin, who is a member of the Christian Scientists Committee on Publication for Northern-Eastern Australia, also expressed concern at the prospect of having to bar people from attending services.
"It's very hard to turn someone away who's coming to a place of worship, where they feel their spiritual needs are going to be met," she said. Currently, her church in Brisbane is permitted to host in-person services subject to COVID-19 check-ins and social distancing.
"If it was mandated to only those that were vaccinated, the only thing I could think [of to do] would be to go to hybrid services where we have both in-person and virtual," she said. "We would just abide by whatever was required and do our best."
If this situation arises, Dr Barker said any challenge would likely come down to an assessment of the health risk versus the benefit of allowing people to practice their religion freely.
"We don't actually yet know what the actual effect is going to be," she said. "We could have lots of people saying 'I'm not vaccinated but I want to go to the mosque for Friday prayers', or we could have absolutely nobody.
"That's what we don't know at this point."
https://www.msn.com/en-au/news/australia/is-there-likely-to-be-a-religious-exemption-for-the-covid-19-vaccine/ar-AAOMVkS
**************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Sunday, September 26, 2021
Alcohol is good for you
I have just put up a post to that effect on my Food & Health blog
**************************************
Australia has been a big user of AstraZeneca vaccine so has a lot of data on it and the data shows that blood-clotting is rare
The mortality rate from a rare blood-clotting disorder linked to the AstraZeneca COVID-19 vaccine is nearly a fifth of what experts originally thought it could be.
Earlier this year, as data emerged from overseas about the disorder — called TTS for short — it was estimated that the chance of dying if you developed a clot was about 25 per cent.
In Australia, 11.3 million doses of the AstraZeneca vaccine — now called Vaxzevria — have been administered, with a total of 141 people developing a confirmed or probable case of TTS linked to the jab.
Out of those 141 cases, eight people have died of the clots, or around 5.6 per cent.
In the UK, the rate of dying from TTS was 17 per cent. However, research published in August showed in one study it was as high as 22 per cent.
So, how has Australia kept its rate so low?
The head of the national medical regulator, the Therapeutic Goods Administration (TGA), John Skerritt, thinks it is a combination of a few things.
First, we were given a heads-up by what was happening in the UK and Europe. "They'd vaccinated more than 10 million people before we had started to see possible cases," Professor Skerritt said. "Our doctors were able to pick up on the signs and symptoms and treat early. "We also have been able to pick up more less mild cases."
Professor Huyen Tran, a haematologist at Monash University, agreed having information from other countries early on made a big difference.
"I think initially following what we were seeing in Europe I was expecting a higher fatality rate, but I think I'd caveat that by saying they had a much longer run-in," he said.
"So that awareness, that understanding, is difficult early on, so we had that luxury of learning from other places."
Having a national hospital system that has not been completely overwhelmed by COVID-19 cases has also been crucial, allowing people who need treatment to access it quickly.
At the time of writing, 121 people have been discharged from hospital after being treated for TTS, 12 are still currently receiving treatment, but none are in ICU.
Both professors reiterated that the likelihood of even developing a clot is extremely rare and the benefits of protection from COVID-19, and its potentially long-lasting impacts, for most people, outweigh the risk of TTS.
Media coverage raised awareness
Professor Skerritt pointed out the extensive coverage of the rare clotting disorder early on may have played a role in reducing the fatality rate too.
"We are talking about something that is still extremely rare," he said. "The chance of death after a COVID vaccine in general is still well less than one in a million and there are things like being hit by lightning which are more common than that.
"With the media [coverage], it had the negative effect of causing vaccine hesitancy, but it also had the positive effect of making sure that our doctors and people and individuals were aware of the potential side effects.
"So, they'd go and see their doctors and hospitals early if they had, say, a really bad headache after getting the vaccine."
Professor Tran also believes the heightened awareness of symptoms has played a role in the successful treatment of clots in younger people, which tend to be more severe.
"I can think of an immediate example. The youngest individual that I've been involved with is actually a 22-year-old female," he said. "She presented to the emergency room within about 18 hours of the onset of symptoms with some insistence from her family. We picked up [on signs of TTS] that day and it was critical.
"She's done remarkably well so I think early diagnosis … is really, really important."
The other piece of the puzzle is that, according to both Professor Skerritt and Professor Tran, our ability to treat the disorder has also meant fewer deaths. "It's a condition that we now know we can treat really well," Professor Tran said.
"The combination of education, early recognition, has meant early therapy [which] has led to a really good outcome."
*****************************************
Norway dumps all Covid restrictions to ‘live as normal’
Norway has ditched all its Covid-19 measures, even social distancing, in a radical move that as yet has unclear consequences.
On Friday, the Nordic nation’s government announced that it was time to “live as normal” with Covid-19 after 561 days of enduring some kind of restriction, whether that be venue capacity limits or stay-at-home orders.
Now, Norwegians can attend restaurants, night clubs, sporting events and anything else at full capacity, with social distancing thrown out the window.
They’ve even started encouraging travel outside of Europe, removing travel warnings.
The new rules come into effect on Saturday, 4pm local time.
“It is 561 days since we introduced the toughest measures in Norway in peacetime … Now the time has come to return to a normal daily life,” Prime Minister Erna Solberg told reporters. “In short, we can now live as normal.”
That’s despite the nation of five million people having 67 per cent fully vaccinated — lower than Australia’s “magic number” of reopening, at 80 per cent.
The extreme move is part of a four-step plan to scrap all restrictions implemented on March 10 last year. Norway was up to the final step but it was postponed several times over fears of rising infections.
The country’s health Minister sent a letter to municipalities alerting them to prepare for the ending of restrictions.
Like most countries, Norway was hit hard by the delta strain of the coronavirus. In total, the country has recorded nearly 186,000 local cases of Covid-19 and has tragically had 850 deaths. For comparison, Australia has had more than 93,000 cases to date and 1,208 deaths. In the last 24 hours, Norway has recorded 705 new cases.
However, its health body, the Norwegian Institute of Public Health, recommended that society be reopened.
According to Reuters, Norway has had 98 infections per 100,000 people in its population.
Globally, there have been 230 million cases of Covid-19, with 4.7 million deaths and more than 6 billion doses of vaccine administered.
The 67 per cent vaccination figure counts the entire population, including children, not just its eligible adults.
Earlier this month, the Pfizer vaccine was opened up to 12-15-year-olds.
According to the nation's health body, 90.6 per cent of adults have received their first jab, while 83.8 have received their second dose.
That puts the nation ahead of Australia, which sits at 50.9 per cent of people 16 and over fully-vaccinated, and 75.4 per cent getting their first jab, according to the Federal Government.
Last week, Norway's Covid infection levels decreased by 33 per cent compared to the week before, while hospital admissions dropped from 95 to 67 as vaccinations caught up with the virus, according to Life In Norway.
The Norwegian government said its citizens didn’t have to live a Covid-normal life if they didn’t want to.
“When the authorities‘ advice and rules essentially disappear, the individual can choose for themselves what risk they want to take and what measures they want to practice,” they said in a statement.
Norway is the second Scandinavian country to end the restrictions, following in the footsteps of Denmark who waved goodbye to lockdowns on September 10.
The UK has also adopted a largely “Covid-normal” existence although case numbers continue to flare.
Singapore adopted a similar approach in July but backflipped in less than two weeks after the plan failed miserably.
Infections went from eight to almost 200 in 10 days, prompting restrictions to be brought back for the Asian country.
In fact, on Saturday, Singapore had to tighten its restrictions even further with only groups of two allowed in restaurants and children having to switch to at-home learning, despite the nation hitting an 80 per cent double dose rate.
The news of Norway’s new-found freedom is an extra slap in the face for NSW and Victorian residents, who are both in the throes of a months-long lockdown.
The UK and Denmark are yet to backtrack on their radical move to end Covid rules entirely. It remains to be seen whether Norway will do the same.
******************************************
IN BRIEF
Democrat leaders Chuck Schumer and Nancy Pelosi say they have a deal on tax increases (Washington Examiner) | Except several Senate Democrats undercut claims of unity (Washington Times)
FBI: Murder rate soared in 2020, highest year-over-year increase ever recorded (Daily Wire)
Joe Biden, who demands people “pay their fair share,” may owe up to $500,000 in back taxes (Daily Wire)
Hunter Biden requested more than $2 million to unfreeze Libyan assets when dad was VP (Free Beacon)
January 6 committee subpoenas four from Trump’s inner circle (Politico)
House Republicans just callously voted to draft our daughters — and GOP senators will too (The Federalist)
No joke: Biden administration stops Border Patrol from using horses in Del Rio (Fox News)
U.S. special envoy to Haiti resigns, citing “inhumane” deportation of Haitians (PBS)
Democrats feud as House approves $1 billion for Israel’s missile system (New York Times)
Dems plan to scuttle Space Force (Free Beacon)
CDC director defies advisory panel, recommends COVID booster for younger at-risk workers (Fox News)
CDC quietly removed school guidance for eliminating masks, rolling back COVID prevention efforts (Fox News)
New York health commissioner resigns after criticism over nursing home scandal (Bloomberg)
Oregon nanny state officials say you can kiss on dates — if both vaccinated (Fox News)
GOP-led Arizona election review closely matches Biden’s winning margin (Politico)
2024: Trump over Biden by 10 points, Harris by 13 (Washington Examiner)
**************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Friday, September 24, 2021
Group most at risk of being hospitalised and killed by Covid despite vaccination
The world is experiencing the largest vaccination event in history in its attempt to deal with the global coronavirus pandemic. But despite the marked effectiveness of the various vaccines, there is still a risk – albeit small – of “breakthrough” cases.
Now a new study has identified those unlucky few who are most at risk of ending up with a serious case of Covid despite having had the jab.
Some 5.7 billion Covid-19 vaccinations have already been administered worldwide. And their effectiveness is evident, as previously locked down nations begin to reopen and pressure on hospitals starts to ease.
According to data collected by the Royal Institution of Australia’s Cosmos magazine, 92 per cent of those dosed with AstraZeneca can fight off the virus before it gets bad enough for hospitalisation. In the case of Pfizer, that figure is about 96 per cent.
“It’s clear that the vaccines are highly effective, and without them we would be facing a much deadlier pandemic,” says Yale University associate professor of medicine (cardiology) Hyung Chun.
However, among the vaccinated, there will still be a few who still suffer severe illness. And these are who the Yale study has sought to identify.
Those most at risk of severe illness
Yale studied 969 instances of Covid-19 over 14 weeks between March and July in its local New Haven Health System.
Of these, just 54 had been fully vaccinated. “The majority of fully vaccinated patients experience mild or no symptoms if infected with SARS-CoV-2,” Dr Chun says.
Of the 54 “breakthrough” cases, just 14 advanced to a severe stage. Four ultimately needed emergency intensive care. Three died.
“These cases are extremely rare, but they are becoming more frequent as variants emerge and more time passes since patients are vaccinated,” Dr Chun says.
According to the study, most of the severe cases were aged between 65 and 95. Many had pre-existing conditions, especially type-2 diabetes and heart disease. Some had been taking immune-system suppressing medications.
Again, those “breakthrough” deaths must be put into perspective.
The US Centres for Disease Control and Prevention (CDC) said that, as of August 30, it knew of 12,908 vaccinated Covid-19 patients who had needed hospitalisation. Those who died amounted to fewer than 0.008 per cent of America’s vaccinated population.
Arms race
Dr Chun pointed out that many of the patients in the March to July study did not have the highly infectious Delta variant of Covid-19. How much this mutation has changed the equation is yet to be determined.
Covid-19 – essentially the same type of virus as the common cold – shows the same tendency to adapt to vaccinations over time. Exactly how fast and by how much remains to be seen.
Monash University virologist Dr Vinod Balasubramaniam says Delta has become the dominant variant worldwide, “causing spikes in new and breakthrough infections” among vaccinated populations.
“There is some indication that the Delta variant may also result in more severe disease,” he says.
And the imprint vaccines leave on the body’s immune system are not permanent.
The Royal Institution of Australia’s Elizabeth Finkel says a UK preprint shows Pfizer effectiveness waning from 90 per cent to 78 per cent after three months. AstraZeneca’s strength fell from 69 per cent to 61 per cent over the same time frame.
But Covid’s previous behaviour remains the best indicator of future trends.
Those most likely to be at risk of severe illness, Dr Chun says, are those with existing health conditions.
“Identifying who is more likely to develop severe Covid-19 illness after vaccination will be critical to ongoing efforts to mitigate the impact of these breakthrough infections,” the Yale report reads.
“As effective as the vaccines are, with emerging variants and increasing cases of breakthrough infections, we need to continue to be vigilant in taking measures such as indoor masking and social distancing,” Dr Chun says.
Dr Vinod agrees: “We must first understand that the vaccines we have currently are not a miracle cure. They were designed to provide immunity against symptoms caused by the virus and the possibility of reducing transmission of the virus from person to person.”
Many researchers expect Covid-19 to become a seasonal infection, like the flu virus.
People will gradually develop a degree of immunity through both illness and vaccination, and this will protect most from severe disease.
But, like the flu, future Covid is still likely to have a severe impact upon some.
“Having had Covid-19 is unlikely to give you lifelong immunity,” says Dr Vinod. “But, even if you are infected again, the second infection will likely be less serious. We might need booster doses against variants and to provide optimal immunological memory against the disease.
“If SARS-CoV-2 experiences antigenic evolution at rates that are similar to influenza, annual shots for vulnerable populations may well be necessary.”
*******************************************
10,000 Unnecessary Cancer Deaths Linked to COVID-19 Pandemic, Lockdown in UK
A lack of face-to-face doctor visits in the UK since the start of the COVID pandemic may result in 10,000 unnecessary deaths due to cancer, according to a report from University College London published this week.
Researchers with the university stated that a drop in emergency referrals from general practitioners in 2020 across the United Kingdom resulted in some 40,000 late diagnoses of cancer. The delays, combined with longer National Health Service (NHS) treatment due to the pandemic, mean that thousands will die “significantly earlier” from cancer, the report found.
The study found that more than 60 percent of people surveyed by the university were concerned about talking to their general practitioner (GP) about “minor health problems” amid the pandemic. Before the CCP virus’s spread, around 80 percent of appointments with doctors were in person, but only 57 percent of consultations were face-to-face in July, the report noted.
“The immediate effect of the pandemic was to delay early diagnosis. Even before the pandemic, Britain’s performance was not up there with the best of the world,” said report co-author David Taylor, a professor with University College London, according to The Telegraph.
“There is some evidence to suggest every month treatment is delayed can increase the risk of early death by seven percent,” he said. “Some of it is about patients not presenting, worrying about being a burden on their GP, some of it is about access problems.”
In October 2020, a report from health care analyst firm Dr Foster stated that the NHS’s guidance that residents should “Stay Home, Protect the NHS, Save Lives” scared patients away from seeking medical attention last year.
Dr Foster Director of Strategy and Analytics Tom Binstead said of the report last year: “Overall, the analysis suggests that the long-term effects of the pandemic are likely to be far-reaching, with a future spike in demand possible due to missed diagnoses and postponed procedures.
“Cancers may now require a greater level of treatment, or even be untreatable, if they have been left undetected or untreated as a result of the crisis.”
A spokesperson for the NHS told The Telegraph and other news outlets on Sept. 21 that during the pandemic, the agency prioritized individuals who sought care for cancer.
Services for cancer are at “pre-pandemic levels,” while the latest monthly figures suggest “more than 200,000 people referred for checks and more than 27,000 starting treatment,” the spokesperson said.
**********************************************
New COVID-19 Variant With ‘Unique Mutations’ Discovered at Kentucky Nursing Home
A new variant of the COVID-19 virus has been discovered at a Kentucky nursing home, where it has reportedly infected 45 residents and health care personnel, according to scientist William A. Haseltine.
The variant, called R.1, originated in Japan and infected many residents and workers in the Kentucky nursing home who were fully vaccinated, Haseltine said.
R.1 has now received more than 10,000 entries in the GISAID SARS-CoV-2 database, the world’s largest database that researchers use to track and record genomic data.
“The variant contains five mutations previously noted in variants of concern or interest … It also contains many unique mutations,” Haseltine wrote for Forbes.
“R.1 is a variant to watch. It has established a foothold in both Japan and the United States. In addition to several mutations notably in the spike and nucleocapsid protein in common with variants of concern, R.1 has a set of unique mutations that may confer an additional advantage in transmission, replication, and immune suppression.”
Haseltine’s comments come just days after the Food and Drug Administration’s (FDA) vaccine advisory panel voted to recommend against providing Pfizer booster vaccines to the general public, but recommended the shots for Americans aged 65 and older and for those who are at high risk, dealing a blow to the Biden administration’s vaccination agenda.
While U.S. health officials, some other countries, and vaccine makers have argued that boosters are needed for everyone, many scientists, including some inside the FDA, have disagreed, noting that regulators haven’t yet independently verified all of the available data.
Some FDA staff have also noted that it isn’t currently clear if those who receive a booster dose would have an increased risk of adverse reactions, such as myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the outer lining of the heart).
Since April, increased cases of myocarditis and pericarditis have been reported in the United States following vaccinations using the Pfizer-BioNTech and Moderna vaccines, most notably among adolescents and young adults, according to the Centers for Disease Control and Prevention.
A recent study from several top scientists at the World Health Organization (WHO) and FDA has also found that the general population doesn’t need a booster dose and instead called for current supplies of vaccines to be given to unvaccinated populations, such as low-income countries.
“Even if boosting were eventually shown to decrease the medium-term risk of serious disease, current vaccine supplies could save more lives if used in previously unvaccinated populations,” the authors wrote.
******************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Thursday, September 23, 2021
Anti-viral drug remdesivir reduces risk of hospitalization in high-risk COVID-19 patients by 87% when given early
Trump was right!
Remdesivir reduces the risk of hospitalization and medical visits due to COVID-19 in high-risk patients, new data suggest.
California-based Gilead Sciences Inc, the maker of the antiviral drug, published the results of its Phase III clinical trial on Wednesday.
Researchers found patients treated with remdesivir were 87 percent less likely to be hospitalized and 81 less likely to require a medical visit than those who were given a placebo.
The team says the findings shows that remdesivir, the only drug fully approved to treat severely ill coronavirus patients, can also be used for those who are at-high risk of becoming seriously ill - but are still early on in their infection.
Remdesivir was developed Gilead to treat Ebola, the deadly fever that emerged in West Africa in 2014.
While it was unsuccessful in treating Ebola, the drug appears to interfere with the ability of the coronavirus to copy its genetic material.
In April 2020, the National Institutes of Health (NIH) released results from a study that found remdesivir helped patients recover 31 percent faster.
This led to the U.S. Food and Drug Administration (FDA) issuing emergency use authorization for the drug the following month.
A few months later, in October 2020, the FDA fully approved the drug of the use in adults and in pediatric patients ages 12 to 17 who require hospitalization.
The new trial, however, shows that the treatment may also be effective in treating patients before they are hospitalized.
Researchers looked at 562 participants at high-risk of developing severe COVID-19, of whom half were given remdesivir and the other half a placebo.
After four weeks, 5.3 percent of the placebo group were hospitalized compared to 0.7 percent of the placebo group.
The team said that this suggests the medication reduces the risk of hospitalization by 87 percent.
Additionally, the trial looked at any patients who required medical visits due to COVID-19. day 28, 8.3 percent of the placebo group had sought medical care in comparison with 1.6 percent of the treatment group.
Researchers say this means the drug reduces the risk of a medical visit by 81 percent.
'Antiviral medications provide maximal benefit when used early in the disease course,' Dr Robert Gottlieb, principal investigator at Baylor University Medical Center and Baylor Scott & White Research Institute, said in a statement.
'We are seeing very high numbers of hospitalized patients as new COVID-19 infections surge, placing increased demands on already over-burdened healthcare systems.
'Remdesivir, also known as Veklury, is an effective antiviral for the treatment of hospitalized patients with COVID-19 and an essential tool to help reduce disease progression.'
***************************************
HOW COVID AFFECTS MEN’S SEXUAL HEALTH
There’s no shortage of misinformation out there about the coronavirus, and some of the most pernicious claims swirl around vaccines and fertility. With apologies to Nicki Minaj, there is no credible scientific evidence that any of the COVID-19 vaccines cause impotence. However, there is now a wealth of data that shows getting infected with this virus can cause erectile dysfunction and other reproductive health problems for men.
Crucially, getting a vaccine is not the same thing as contracting a disease. Vaccines are designed to provoke an antibody response, and the ones approved or authorized for use in the U.S. don’t even contain dead or weakened versions of the virus. They instead use pieces of its genetic material to train the body’s immune system. (Pictured above, a man getting a rapid COVID-19 test.)
By contrast, coming down with COVID-19 allows the virus to replicate in your cells, and as Sharon Guynup reports this week, several studies show that the SARS-CoV-2 virus can invade tissues in the penis and testicles. As it happens, the testicles are a perfect hideout for a variety of viruses because they are immunologically privileged body parts, meaning they are shielded from the immune system. Once COVID-19 invades this region, it can hang out there indefinitely. “This may explain why 11 percent of men hospitalized with COVID-19 suffered testicular pain,” Guynup writes.
Other studies have found that men seem to be six times more likely to develop brief or long-term erectile dysfunction after contracting the virus. That’s likely because the coronavirus is known to attack blood vessels all over the body, and the penis relies on blood vessels to maintain an erection. Cells also become oxygen-deprived when blood vessels narrow, which means the surrounding tissues become inflamed and the vessels lose elasticity. “No oxygen, no sex,” says Emmanuele A. Jannini, a professor at the Tor Vergata University of Rome.
These kinds of health repercussions can be difficult to track because patients may be embarrassed or self-conscious. And it can be tough to report on them and not invite readers to dissolve into giggles with an unintentional pun. But this is serious science that deserves to be taken seriously. According to the New England Journal of Medicine, 10 percent to 30 percent of people infected with the virus—at least 42 million cases in the U.S. and 226 million worldwide—experience a range of ongoing symptoms collectively called long COVID. People can develop these debilitating symptoms even after a mild or asymptomatic infection. And the list includes several reproductive health problems for men, from sexual dysfunction and swollen testicles to mental health issues that decrease arousal.
Research is still in progress, and plenty of unknowns remain. But it’s clear enough by now that if you care about your reproductive health, you should be more worried about getting the virus than the vaccine. “The plausible relationship between COVID-19 and erectile dysfunction is one more reason for the unvaccinated to get their shots,” Jannini says. “If they want to have sex, better to get the vaccine.”
https://www.nationalgeographic.com/science/article/covid-19-may-impair-mens-sexual-performance
*************************************IN BRIEF
Supreme Court to hear oral arguments challenging Roe v. Wade on December 1 (Washington Examiner)
Justices will also weigh New York’s limit on carrying a handgun (Washington Times)
Democrats/Leftmedia mistake horse reins for “whips” in Border Patrol footage (Post Millennial)
Joe Biden’s agenda is hanging by a thread as Democrats threaten to tank two major bills (BuzzFeed)
Only 49% think Biden is mentally stable enough to be president (Breitbart)
Shades of Donald Trump: Biden administration asks Pentagon to send military to border (Washington Examiner)
Biden to raise refugee admissions cap to 125,000 (Washington Post)
CIA chief team member reported Havana syndrome symptoms during trip to India (The Hill)
North Korea’s nuclear program going “full steam ahead,” IAEA says (Reuters)
Stateside COVID death toll surpasses 1918 flu fatalities (Axios)
U.S. to ease travel restrictions for vaccinated foreign visitors (CNBC)
S&P 500 fell 1.7% on Monday for its worst day since May; Dow sheds 600 points (CNBC)
The great holiday supply chain shortage (Axios)
“Back to square one”: Justin Trudeau’s liberals win Canada election but missed the majority in parliament (AP)
UK court decides kids under 16 can take puberty-blocking drugs without court approval (Daily Signal)
Civil suit filed against Texas doctor who violated abortion ban in the first test of law’s constitutionality (Washington Examiner)
Emmy viewers call out hypocrite celebs for not wearing masks and social distancing (Fox News)
Here’s how Chuck Schumer is trying to gaslight the GOP on debt (Daily Beast)
Policy: Heaping on the SALT: Democrats press Biden to reinstate a tax break for the wealthy (City Journal)
Policy: Why Taiwan matters to the world (Heritage Foundation)
******************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Wednesday, September 22, 2021
Vaccines that grow on leaves and don't need needles: A look at COVID jabs you may not have heard of
You've heard of Pfizer, Moderna and AstraZeneca, but what about Medigen and Zydus Cadila?
In the race to vaccinate the world and in the face of supply issues and sanctions, some countries have developed homegrown vaccines.
There are geopolitics and vaccine nationalism at play, but the pandemic has seen a flurry of vaccine development – from the first-ever DNA vaccine to one grown on leaves.
While a lot of these vaccines sound new, the science and technologies they're built on have been around for a long time.
As ANU virologist David Tscharke notes, vaccine development is a tough business – in the past, if a vaccine already existed for a disease it was difficult to break through with a new idea.
But the pandemic has blown the field wide open.
"Nobody knew who was going to be first, nobody knew if the first one would work," Professor Tscharke said.
"So there was an enormous push into all of these really interesting vaccine technologies."
But they all basically work in the same way – telling the body to build up an immune response, so if they ever get infected with the virus, the body knows what to do.
The world's first DNA vaccine
India has often been called the pharmacy of the world, but it's not just manufacturing vaccines — it's researching and developing them too.
The homegrown vaccine from Zydus Cadila stands out for a bunch of reasons — it's the world's first DNA vaccine, and it's also needle-free. It carries the genetic code for the coronavirus spike protein, which the body can then read and generate an immune response.
The vaccine, called ZyCoV-D, was approved on August 20 and is delivered via a jet injector, sometimes called a gene gun.
It uses a high-pressure stream of fluid to blast it into the cells of the skin.
Some other DNA vaccines being developed are delivered by a patch, which is embedded with hundreds of tiny needles coated in the vaccine.
DNA vaccines don't need to be stored at low temperatures like mRNA vaccines such as Pfizer and Moderna.
ZyCoV-D has a reported efficacy of 67 per cent — lower than some other vaccines but still above the World Health Organization's 50 per cent threshold. It requires three doses.
Iran has been the worst-hit country in the Middle East and was battling a fifth wave that appeared to peak at 50,000 daily cases and 700 daily deaths last month.
In January this year, Iran's supreme leader banned the import of Pfizer and AstraZeneca, saying he didn't trust the US- and UK-made jabs.
Later, Iran did end up importing AstraZeneca that was manufactured in other countries, such as Russia or South Korea, and the new government last week approved the single-dose Johnson & Johnson.
But in the meantime, the country developed its own vaccine — COVIran Barekat — which was approved for emergency use in mid-June, before phase three trials were complete.
Early phases in clinical trials reported an efficacy of more than 90 per cent, but results have not yet been peer-reviewed.
It's an inactivated vaccine, meaning it's made by growing the virus, then killing or inactivating it. It's a similar type to China's Sinopharm vaccine — which has been the most administered in Iran.
Iran has also said US sanctions have hindered their efforts to get vaccines, but it can access them through COVAX.
"There are some countries that are under quite a lot of sanctions. So Iran is a country where it's quite difficult for them to access things depending on what the political situation is," Professor Tscharke said.
Although the US sanctions do not include medicines, in practice they have deterred international banks from financial transactions involving Iran — something that the Human Rights Watch in the past has said can have knock-on effects for Iranians' access to health care.
Taiwanese President Tsai Ing-wen made a soft-power move last month when she got her first vaccine — a home-grown variety called Medigen.
Taiwan was upheld as a poster child early on in the pandemic, keeping the virus largely under control for more than a year.
But a spike in infections in May this year highlighted the island's low vaccination rates, with only about 1 per cent vaccinated against COVID-19 at the start of that outbreak.
Taiwan refused Chinese vaccines like Sinopharm and Sinovac and instead accepted donations of AstraZeneca from Japan and Moderna from the US.
Medigen is a subunit protein vaccine, like Novavax, and its Chinese name means "high end".
The President said she wasn't nervous when she received her jab, but Medigen hasn't undergone phase three trials — due to be tested in Paraguay.
It was granted emergency approval in July amid criticism from the opposition that its approval was rushed.
Cuba has approved three vaccines for emergency use — the Abdala vaccine, Soberana 2 and single-dose Soberana Plus, and the country has another two jabs in development.
All are protein subunit vaccines, like Medigen or Novavax, and Soberana Plus can work as a booster shot.
Soberana Plus, according to the New York Times, is also tailored for those who have had COVID-19 before, in what was described as a world first.
Cuba, which is renowned for its healthcare system and has a long history of developing vaccines, has injected some national pride in its vaccine names.
Abdala is named after a poem by young revolutionary and independence hero Jose Marti, while Soberana 2 means "sovereign".
Earlier this month, Cuban authorities began inoculating toddlers as young as two years old with Soberana 2.
It has also been approved for use in Iran, while Abdala has now been approved in Vietnam.
Can vaccines grow on trees?
The majority of the world's flu vaccines are grown in chicken eggs, but Canada-based Medicago is opting for plants for its COVID-19 vaccine.
Professor Tscharke said while protein for vaccines often is grown in fermenters or vats in factories, it's possible to use a plant instead, which can be quick and inexpensive.
The idea behind this one is that it contains proteins that mimic the structure of the virus, but does not contain genetic material.
The vaccine is grown in a wild species indigenous to Australia and is related to tobacco, and the company is partially funded by cigarette maker Philip Morris International.
The plant-based vaccine is still ultimately injected, but Professor Tscharke says the broader idea of growing vaccines on plants is another platform given a push during the pandemic.
There have also been high hopes for further development of oral and edible vaccines, he said.
"People have liked the idea that you could eat your vaccines … I remember somebody who wanted to have a polio vaccine in the banana."
****************************************
CDC studies show waning vaccine effectiveness against hospitalization in elderly
Covid-19 vaccines continue to work well at preventing severe disease for the vast majority of Americans but they are becoming less effective at blocking infection, according to a series of studies the Centers for Disease Control and Prevention released Friday.
Two of the analyses suggest that as the Delta variant spread this summer, the shots became less effective at keeping people 75 and older out of the hospital.
Breakthrough infections are still rare, and unvaccinated people still face significantly higher risks of illness and death from the virus. They were about 4.5 times more likely to become infected, and more than 10 times more likely to need hospitalization or die from Covid-19 than were fully vaccinated people. But the three new studies add to recent evidence that vaccines’ protection against infection ebbs over time.
CDC began last month to release the results of targeted vaccine effectiveness studies, showing protection against infection beginning to wane in residents of New York and Los Angeles and among frontline health care workers. But the agency has taken weeks to complete one of its largest and most comprehensive analyses of breakthrough infections — based on data from 13 jurisdictions with the ability to match immunization records with Covid-19 lab reports.
That study, one of the three released Friday, compared the relative risks of infection, hospitalization and death between people who are fully vaccinated and those who are not across different age groups. The CDC looked at 600,000 people infected with Covid-19 from April through mid-July. It found that overall, vaccine effectiveness against severe Covid-19 disease remains high. Incidence rate ratios for hospitalization and death changed relatively little after the Delta variant became the most dominant strain of the virus in the U.S., the study showed.
But the vaccines’ ability to prevent any infection — including mild disease — decreased from 91 percent to 78 percent after the Delta variant took over this summer.
Between April 4 and June 19, before Delta’s rise, fully vaccinated people accounted for 5 percent of cases, 7 percent of hospitalizations and 8 percent of deaths. Those figures roughly doubled between June 20 to July 17 as the variant spread. Fully vaccinated individuals accounted for 18 percent of cases, 14 percent of hospitalizations and 16 percent of deaths.
The CDC also released two reports that looked more closely at hospitalizations associated with the Delta variant and vaccine effectiveness.
One of those reports pulled on data from 1,175 patients 18 and older who were hospitalized at five Department of Veterans Affairs facilities between February and August. VA hospitals generally treat people who are older, with a higher prevalence of underlying medical conditions, than the general population.
The vaccines were 87 percent effective overall at preventing hospitalization, protection that remained relatively consistent before and after Delta became the country’s dominant variant, the study shows. But that figure masks notable differences between age groups. The shots were only 80 percent effective at keeping adults over 65 from being hospitalized with Covid, while they were 95 percent effective for people between ages 18 and 64.
https://www.politico.com/news/2021/09/10/cdc-waning-vaccine-immunity-elderly-511206
******************************************Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Tuesday, September 21, 2021
Shunning Vaccination, But Lining Up For Antibodies
A Costly Therapy Soars in the Unvaccinated
Lanson Jones did not think that the coronavirus would come for him. An avid tennis player in Houston who had not caught so much as a cold during the pandemic, he had refused a vaccine because he worried that it would spoil his streak of good health.
But contracting Covid shattered his faith in his body’s defenses — so much so that Mr. Jones, nose clogged and appetite vanished, began hunting for anything to spare himself a nightmarish illness.
The answer turned out to be monoclonal antibodies, a year-old, laboratory-created drug no less experimental than the vaccine. In a glass-walled enclosure at Houston Methodist Hospital this month, Mr. Jones, 65, became one of more than a million patients, including Donald J. Trump and Joe Rogan, to receive an antibody infusion as the virus has battered the United States.
Vaccine-resistant Americans are turning to the treatment with a zeal that has, at times, mystified their doctors, chasing down lengthy infusions after rejecting vaccines that cost one-hundredth as much. Orders have exploded so quickly this summer — to 168,000 doses per week in late August, up from 27,000 in July — that the Biden administration warned states this week of a dwindling national supply.
The federal government, which was already covering the cost of the treatment — currently about $2,100 per dose — has now taken over its distribution as well. For the coming weeks, the government has told states to expect scaled-back shipments because of the looming shortages.
With seven Southern states accounting for 70 percent of orders, the new process has unsettled some of their governors, who have made the antibody treatment central to their strategy for enduring a catastrophic wave of the Delta variant.
More supplies are on the way. The federal government bought 1.8 million more doses this week, expected to arrive in the fall and winter. But for now, some hospitals are uncertain of supplies, state health officials said, even as patients keep searching for doses.
“We have providers struggling to get the necessary product,” Kody Kinsley, who leads operations for North Carolina’s Covid-19 response, said in an interview. “I think what has happened is a classic logistics issue, where all of a sudden there’s much more demand.”
Amid a din of antivaccine messages, monoclonal antibodies have become the rare coronavirus medicine to achieve near-universal acceptance. Championed by mainstream doctors and conservative radio hosts alike, the infusions have kept the country’s death toll — 2,000 per day and climbing — from soaring even higher.
And after months of work by President Biden and Southern governors to promote the treatments, they have won the affection of vaccine refusers who said that the terrors and uncertainties of actually getting Covid had made them desperate for an antidote.
“The people you love, you trust, nobody said anything negative about it,” Mr. Jones said of the antibody treatment. “And I’ve heard nothing but negative things about the side effects of the vaccine and how quickly it was developed.”
Some Republican governors have set up antibody clinics while opposing vaccine mandates, frustrating even some of the drugs’ strongest proponents. Raising vaccination rates, scientists said, would obviate the need for many of the costly antibody treatments in the first place. The infusions take about an hour and a half, including monitoring afterward, and require constant attention from nurses whom hard-hit states often cannot spare.
“The people you love, trust, nobody said anything negative about it,” said Lanson Jones.“The people you love, trust, nobody said anything negative about it,” said Lanson Jones.
“It’s clogging up resources, it’s hard to give, and a vaccine is $20 and could prevent almost all of that,” said Dr. Christian Ramers, an infectious disease specialist and the chief of population health at Family Health Centers of San Diego, a community-based provider. Pushing antibodies while playing down vaccines, he said, was “like investing in car insurance without investing in brakes.”
The government-supplied monoclonal antibodies, made by Regeneron and Eli Lilly, have been shown to significantly shorten patients’ symptoms and reduce their risk of being hospitalized — by 70 percent, in the case of Regeneron’s antibody cocktail. The treatments, given in a single sitting, use lab-made copies of the antibodies that people generate naturally when fighting an infection.
Patients and doctors alike overlooked the treatments during the wintertime surge of infections. But hospitals and health centers have now ramped up their offerings, transforming dental clinics, mobile units and auditoriums into infusion centers. In states like Texas, where elective surgeries have been postponed to make room for Covid-19 patients, operating room nurses have been enlisted to give infusions.
One factor driving the demand is that many patients, including vaccine skeptics, have been spreading the word about their seemingly miraculous recoveries.
“They’re like, ‘I have Covid, I want this treatment, my friend or family told me about this,’ ” said Jennifer Berry, the Houston Methodist nursing director of infusion services. “Now the word is out.”
At Houston Methodist, nurses administered nearly 1,100 treatments across eight sites in the first week of September, well more than twice as many as any week last winter. The hospital reduced the average time between orders and infusions to two days this month from three days in early August, giving patients a better chance of fighting off infections.
Juggling the infusions with more seriously ill Covid patients this summer forced the hospital, in one case, to move a monoclonal antibody clinic to a strip mall storefront.
But the Texas health department has helped, providing 19 nurses for a different Houston Methodist infusion clinic, said Vicki Brownewell, the lead administrator for the hospital’s program. The Biden administration has also invested $150 million in expanding access to monoclonal antibodies, and Houston Methodist has used federal money to arrange medical taxis for patients struggling with transportation.
Even so, the infusions remain inaccessible to many. Given the heavy demands on staff and the need to create separate infusion rooms for infectious patients, certain communities, especially in rural areas, do not have clinics.
In San Diego, Dr. Ramers said, some large, for-profit hospitals have decided not to administer the antibodies at all because of the logistical hassles, leaving wealthier, well-insured patients to hunt down doses at his publicly funded clinic. Some nurses that he hired for infusions left for short, betterpaying assignments in hard-hit intensive care units.
“The natural, capitalist incentives for health care organizations that are for profit don’t really favor doing this,” Dr. Ramers said. “It’s a lot of work.”
Of the 2.4 million monoclonal antibody doses shipped nationally, at least 1.1 million have been used. Precisely how many are still sitting on shelves is hard to determine because of reporting gaps. Still, waning federal supplies and soaring demand from less-vaccinated Southern states have caused what several states have described as large shortfalls in deliveries.
North Carolina providers have requested 15,000 weekly doses, the health department there said, more than double what the federal government has allocated. Florida said its latest weekly allotment left clinics there 41,000 doses short of what they wanted.
Crushing demand in Southern states as the unprotected fall ill.
Hospitals had previously been able to order the drugs themselves. But the Department of Health and Human Services will now decide how many doses each state receives based on case rates and use of the treatment. State governments, in turn, will decide on doses for individual sites.
The new ordering process, which the Biden administration said would ensure “equitable distribution,” has unsettled some backers of the drug. Gov. Ron De- Santis of Florida, a Republican, warned on Thursday that state officials were unprepared for the new responsibility of parceling out doses.
And in heavily vaccinated states, like New York, people coordinating treatments fear that shipments will plummet because of low case rates, leaving hospitals with so few doses that they shutter their programs. Some hospitals recently reported growing numbers of vaccinated patients receiving infusions.
Diana Berrent, the founder of Survivor Corps, which has worked to help patients find monoclonal antibody treatments, said that involving state governments would create delays: “You’re layering in 50 new layers of bureaucracy,” she said.
Doctors have warned that antibody treatments alone cannot keep pace with ballooning outbreaks. Whereas any one vaccination protects untold others from exposure, a single infusion only helps a single patient. Infusions must be given within 10 days of symptoms; they are unhelpful to most hospitalized patients. And receiving the antibodies once does not keep people from becoming seriously ill if they catch the virus again later.
“Something like that just doesn’t scale,” said Dr. Howard Huang, the medical leader for Houston Methodist’s infusion program.
As a result, health officials have warned that vaccine skeptics may become so enamored of monoclonal antibodies that they become even more resistant to getting a protective shot.
Within days of his infusion, Mr. Jones, the patient in Houston, had left the bedroom where he had been quarantined and returned to his work as a landscape architect. But he was still weighing whether to be vaccinated.
His doctor was pushing for the shot, he said. But the monoclonal antibodies had worked so well that he was tempted to simply return for another infusion if he caught Covid-19 again.
“If I can go get an infusion and feel as good as I do right now, man, I’d rather not take a vaccine that has just been developed,” he said. “That makes me nervous, still.”
https://www.nytimes.com/2021/09/18/health/covid-antibody-regeneron.html
**********************************************Biden Sabotages Lifesaving Antibody Treatment - Sends Less Than Half Needed to FL
The Biden administration is not about saving lives. They are about control, money, and tyranny!
Although lifesaving medications and treatments have been found to work against COVID-19, they continue to fight the distribution of them and instead try to force more vaccines.
This week, Biden's administration sabotaged doses of lifesaving coronavirus antibody treatments being delivered to Florida, sending less than half of what is needed for the week. The admin claims they are prioritizing "equitable distribution," but many suspect that it is revenge against Florida Governor Ron DeSantis and other Republican governors whom Biden vowed to get "out of the way."
The Biden administration this week began to cut the distribution of monoclonal antibodies to red states, such as Florida and Alabama, contending those states, including Texas, Mississippi, Tennessee, Georgia, and Louisiana, are comprising too big a share of the supply in recent weeks — 70 percent.
“HHS will determine the amount of product each state and territory receives on a weekly basis,” said a spokesman for the U.S. Department of Health and Human Services (HHS).
******************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Subscribe to:
Posts (Atom)
